SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-16-104219
Filing Date
2016-03-10
Accepted
2016-03-10 16:01:47
Documents
4
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a16-6090_110ka.htm 10-K/A 40670
2 EX-31.1 a16-6090_1ex31d1.htm EX-31.1 5988
3 EX-31.2 a16-6090_1ex31d2.htm EX-31.2 5438
4 EX-32.1 a16-6090_1ex32d1.htm EX-32.1 11425
  Complete submission text file 0001104659-16-104219.txt   64652
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34921 | Film No.: 161497757
SIC: 2834 Pharmaceutical Preparations